|
"Therapeutic Cloning": Where Do We Go From Here?
Organized by Douglas C. Wallace, Susan V. Bryant, and Peter J. Donovan
Beckman Center of the National Academies, Irvine, CA
October 8-9, 2007
Click on presentation title to watch the slideshow. Additional presentations will be added as they are approved. Speakers' names link to their websites.
Session I: Where are we now?
Opening Remarks, Susan V. Bryant (University of California, Irvine)
Cultural and religious differences in attitudes towards therapeutic cloning and egg donation, Anne Drapkin Lyerly, M.D. (Duke University School of Medicine)
Cross-cultural considerations of cloning using human eggs, Alison Murdoch (Newcastle Fertility Centre at LIFE)
Learning from the Korean experience, Mildred Cho (Stanford University Center for Biomedical Ethics)
Lessons from Dolly, Ian Wilmut (University of Edinburgh)
Session II: Applications of Therapeutic Cloning
Improvement of the efficiency of somatic cell nuclear transfer, Teruhiko Wakayama (RIKEN Center for Developmental Biology)
Deciphering disease progression using nuclear transfer and stem cells, Kevin Eggan (Harvard University)
Histocompatible embryonic stem cells, George Daley (Children's Hospital Boston)
Different nuclei-different expression, Mahendra Rao (Invitrogen Corp)
Keynote Lecture: Fundamentals of cloning, John Gurdon (University of Cambridge)
Session III: De-differentiation and Differentiation
Spindle-associated proteins, Gerald P. Schatten (University of Pittsburg)
Induction of pluripotency by defined factors, Kiichiro Tomoda (The Gladstone Institute, University of California, San Francisco)
Reprogramming somatic stem cells into pluripotent stem cells, Kathrin Plath (University of California, Los Angeles)
Germ cells from stem cells, Renee Reijo Pera (Stanford University)
Session IV: Challenges and Solutions
Culture and genetic modification of germline stem (GS) cells, Takashi Shinohara (University of Kyoto)
Mitochondrial DNA variation in stem cell biology and disease, Douglas Wallace (University of California, Irvine)
Imprinting in stem cells, Roger Pedersen (University of Cambridge)
Closing remarks, Peter Donovan (University of California, Irvine
|
